Decreased zinc availability affects glutathione metabolism in neuronal cells and in the developing brain

Yo Omata, Gabriela A. Salvador, Suangsuda Supasai, Alison H. Keenan, Patricia I. Oteiza

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

A deficit in zinc (Zn) availability can increase cell oxidant production, affect the antioxidant defense system, and trigger oxidant-sensitive signals in neuronal cells. This work tested the hypothesis that a decreased Zn availability can affect glutathione (GSH) metabolism in the developing rat brain and in neuronal cells in culture, as well as the capacity of human neuroblastoma IMR-32 cells to upregulate GSH when challenged with dopamine (DA). GSH levels were low in the brain of gestation day 19 (GD19) fetuses from dams fed marginal Zn diets throughout gestation and in Zn-deficient IMR-32 cells. γ-Glutamylcysteine synthetase (GCL), the first enzyme in the GSH synthetic pathway, was altered by Zn deficiency (ZD). The protein and mRNA levels of the GCL modifier (GCLM) and catalytic (GCLC) subunits were lower in the Zn-deficient GD19 fetal brain and in IMR-32 cells compared with controls. The nuclear translocation of transcription factor nuclear factor (erythroid-derived 2)-like 2, which controls GCL transcription, was impaired by ZD. Posttranslationally, the caspase-3-dependent GCLC cleavage was high in Zn-deficient IMR-32 cells. Cells challenged with DA showed an increase in GCLM and GCLC protein and mRNA levels and a consequent increase in GSH concentration. Although Zn-deficient cells partially upregulated GCL subunits after exposure to DA, GSH content remained low. In summary, results show that a low Zn availability affects the GSH synthetic pathway in neuronal cells and fetal brain both at transcriptional and posttranslational levels. This can in part underlie the GSH depletion associated with ZD and the high sensitivity of Zn-deficient neurons to pro-oxidative stressors.

Original languageEnglish (US)
Pages (from-to)90-100
Number of pages11
JournalToxicological Sciences
Volume133
Issue number1
DOIs
StatePublished - May 2013

Fingerprint

Metabolism
Glutathione
Zinc
Brain
Availability
Dopamine
Oxidants
Pregnancy
NF-E2 Transcription Factor
Glutamate-Cysteine Ligase
Messenger RNA
Transcription
Nutrition
Neuroblastoma
Caspase 3
Dams
Neurons
Rats
Catalytic Domain
Proteins

Keywords

  • γ-Glutamylcysteine synthetase
  • Dopamine
  • Glutathione
  • Neuron
  • Nrf2
  • Zinc
  • Zinc deficiency

ASJC Scopus subject areas

  • Toxicology

Cite this

Decreased zinc availability affects glutathione metabolism in neuronal cells and in the developing brain. / Omata, Yo; Salvador, Gabriela A.; Supasai, Suangsuda; Keenan, Alison H.; Oteiza, Patricia I.

In: Toxicological Sciences, Vol. 133, No. 1, 05.2013, p. 90-100.

Research output: Contribution to journalArticle

Omata, Yo ; Salvador, Gabriela A. ; Supasai, Suangsuda ; Keenan, Alison H. ; Oteiza, Patricia I. / Decreased zinc availability affects glutathione metabolism in neuronal cells and in the developing brain. In: Toxicological Sciences. 2013 ; Vol. 133, No. 1. pp. 90-100.
@article{a02fb7a13df14069b831165918065593,
title = "Decreased zinc availability affects glutathione metabolism in neuronal cells and in the developing brain",
abstract = "A deficit in zinc (Zn) availability can increase cell oxidant production, affect the antioxidant defense system, and trigger oxidant-sensitive signals in neuronal cells. This work tested the hypothesis that a decreased Zn availability can affect glutathione (GSH) metabolism in the developing rat brain and in neuronal cells in culture, as well as the capacity of human neuroblastoma IMR-32 cells to upregulate GSH when challenged with dopamine (DA). GSH levels were low in the brain of gestation day 19 (GD19) fetuses from dams fed marginal Zn diets throughout gestation and in Zn-deficient IMR-32 cells. γ-Glutamylcysteine synthetase (GCL), the first enzyme in the GSH synthetic pathway, was altered by Zn deficiency (ZD). The protein and mRNA levels of the GCL modifier (GCLM) and catalytic (GCLC) subunits were lower in the Zn-deficient GD19 fetal brain and in IMR-32 cells compared with controls. The nuclear translocation of transcription factor nuclear factor (erythroid-derived 2)-like 2, which controls GCL transcription, was impaired by ZD. Posttranslationally, the caspase-3-dependent GCLC cleavage was high in Zn-deficient IMR-32 cells. Cells challenged with DA showed an increase in GCLM and GCLC protein and mRNA levels and a consequent increase in GSH concentration. Although Zn-deficient cells partially upregulated GCL subunits after exposure to DA, GSH content remained low. In summary, results show that a low Zn availability affects the GSH synthetic pathway in neuronal cells and fetal brain both at transcriptional and posttranslational levels. This can in part underlie the GSH depletion associated with ZD and the high sensitivity of Zn-deficient neurons to pro-oxidative stressors.",
keywords = "γ-Glutamylcysteine synthetase, Dopamine, Glutathione, Neuron, Nrf2, Zinc, Zinc deficiency",
author = "Yo Omata and Salvador, {Gabriela A.} and Suangsuda Supasai and Keenan, {Alison H.} and Oteiza, {Patricia I.}",
year = "2013",
month = "5",
doi = "10.1093/toxsci/kft022",
language = "English (US)",
volume = "133",
pages = "90--100",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Decreased zinc availability affects glutathione metabolism in neuronal cells and in the developing brain

AU - Omata, Yo

AU - Salvador, Gabriela A.

AU - Supasai, Suangsuda

AU - Keenan, Alison H.

AU - Oteiza, Patricia I.

PY - 2013/5

Y1 - 2013/5

N2 - A deficit in zinc (Zn) availability can increase cell oxidant production, affect the antioxidant defense system, and trigger oxidant-sensitive signals in neuronal cells. This work tested the hypothesis that a decreased Zn availability can affect glutathione (GSH) metabolism in the developing rat brain and in neuronal cells in culture, as well as the capacity of human neuroblastoma IMR-32 cells to upregulate GSH when challenged with dopamine (DA). GSH levels were low in the brain of gestation day 19 (GD19) fetuses from dams fed marginal Zn diets throughout gestation and in Zn-deficient IMR-32 cells. γ-Glutamylcysteine synthetase (GCL), the first enzyme in the GSH synthetic pathway, was altered by Zn deficiency (ZD). The protein and mRNA levels of the GCL modifier (GCLM) and catalytic (GCLC) subunits were lower in the Zn-deficient GD19 fetal brain and in IMR-32 cells compared with controls. The nuclear translocation of transcription factor nuclear factor (erythroid-derived 2)-like 2, which controls GCL transcription, was impaired by ZD. Posttranslationally, the caspase-3-dependent GCLC cleavage was high in Zn-deficient IMR-32 cells. Cells challenged with DA showed an increase in GCLM and GCLC protein and mRNA levels and a consequent increase in GSH concentration. Although Zn-deficient cells partially upregulated GCL subunits after exposure to DA, GSH content remained low. In summary, results show that a low Zn availability affects the GSH synthetic pathway in neuronal cells and fetal brain both at transcriptional and posttranslational levels. This can in part underlie the GSH depletion associated with ZD and the high sensitivity of Zn-deficient neurons to pro-oxidative stressors.

AB - A deficit in zinc (Zn) availability can increase cell oxidant production, affect the antioxidant defense system, and trigger oxidant-sensitive signals in neuronal cells. This work tested the hypothesis that a decreased Zn availability can affect glutathione (GSH) metabolism in the developing rat brain and in neuronal cells in culture, as well as the capacity of human neuroblastoma IMR-32 cells to upregulate GSH when challenged with dopamine (DA). GSH levels were low in the brain of gestation day 19 (GD19) fetuses from dams fed marginal Zn diets throughout gestation and in Zn-deficient IMR-32 cells. γ-Glutamylcysteine synthetase (GCL), the first enzyme in the GSH synthetic pathway, was altered by Zn deficiency (ZD). The protein and mRNA levels of the GCL modifier (GCLM) and catalytic (GCLC) subunits were lower in the Zn-deficient GD19 fetal brain and in IMR-32 cells compared with controls. The nuclear translocation of transcription factor nuclear factor (erythroid-derived 2)-like 2, which controls GCL transcription, was impaired by ZD. Posttranslationally, the caspase-3-dependent GCLC cleavage was high in Zn-deficient IMR-32 cells. Cells challenged with DA showed an increase in GCLM and GCLC protein and mRNA levels and a consequent increase in GSH concentration. Although Zn-deficient cells partially upregulated GCL subunits after exposure to DA, GSH content remained low. In summary, results show that a low Zn availability affects the GSH synthetic pathway in neuronal cells and fetal brain both at transcriptional and posttranslational levels. This can in part underlie the GSH depletion associated with ZD and the high sensitivity of Zn-deficient neurons to pro-oxidative stressors.

KW - γ-Glutamylcysteine synthetase

KW - Dopamine

KW - Glutathione

KW - Neuron

KW - Nrf2

KW - Zinc

KW - Zinc deficiency

UR - http://www.scopus.com/inward/record.url?scp=84876808500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876808500&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kft022

DO - 10.1093/toxsci/kft022

M3 - Article

C2 - 23377617

AN - SCOPUS:84876808500

VL - 133

SP - 90

EP - 100

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 1

ER -